Welcome to our dedicated page for ARHHD news (Ticker: ARHHD), a resource for investors and traders seeking the latest updates and insights on ARHHD stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect ARHHD's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of ARHHD's position in the market.
Assure Holdings Corp. has received approval for its common stock to be listed on the NASDAQ Capital Market, effective September 29, 2021, under the ticker symbol 'IONM'. This transition from the OTCQB is expected to enhance visibility, increase liquidity, and improve access to capital, according to Executive Chairman John A. Farlinger. Assure continues trading on the TSX Venture Exchange under 'IOM' while maintaining its commitment to delivering high-quality intraoperative neuromonitoring services during surgeries.
Assure Holdings Corp. (OTCQB: ARHH, ARHHD) announced its participation in the Lake Street 5th Annual Best Ideas Growth Conference on September 15, 2021. This exclusive event will feature over 100 publicly traded companies engaging with institutional investors in one-on-one meetings. Assure specializes in intraoperative neuromonitoring services, supporting neurosurgeons and orthopedic spine surgeons with a comprehensive suite of services. The company recently adjusted its common stock trading on the TSX Venture Exchange for eligibility to uplist on NASDAQ.
Assure Holdings Corp. has secured a systemwide contract with Premier Inc., effective November 1, 2021, to offer intraoperative neuromonitoring (IONM) services to Premier members. This agreement marks a significant milestone for Assure, allowing it to provide pricing and terms pre-negotiated by Premier to approximately 4,400 hospitals and 225,000 other providers. The CEO, John A. Farlinger, notes the benefits include facilitated introductions to hospital decision-makers and eligibility to provide IONM services to previously unattainable affiliated hospitals.
Assure Holdings Corp. (OTCQB: ARHH) executed a reverse stock split of 5-for-1 to qualify for NASDAQ listing. This adjustment reduces authorized shares from 900 million to 180 million, with outstanding shares decreasing from 59 million to approximately 11.8 million. The reverse split is aimed at meeting NASDAQ's minimum share price requirements. Trading under the new CUSIP will begin on TSXV on September 8, 2021, with the OTCQB symbol ARHHD reflecting the split for 20 trading days. Assure aims to enhance shareholder value through this uplisting.
